JPS5312851A - Novel phenoxyhydroxypropylamine* its preparation and its application for medical treatment - Google Patents

Novel phenoxyhydroxypropylamine* its preparation and its application for medical treatment

Info

Publication number
JPS5312851A
JPS5312851A JP8826877A JP8826877A JPS5312851A JP S5312851 A JPS5312851 A JP S5312851A JP 8826877 A JP8826877 A JP 8826877A JP 8826877 A JP8826877 A JP 8826877A JP S5312851 A JPS5312851 A JP S5312851A
Authority
JP
Japan
Prior art keywords
phenoxyhydroxypropylamine
novel
preparation
application
medical treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8826877A
Other languages
English (en)
Japanese (ja)
Inventor
Teeron Jiyannmarie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hexachimie SA
Original Assignee
Hexachimie SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexachimie SA filed Critical Hexachimie SA
Publication of JPS5312851A publication Critical patent/JPS5312851A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/42—Singly bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/46—Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D309/06—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
JP8826877A 1976-07-22 1977-07-22 Novel phenoxyhydroxypropylamine* its preparation and its application for medical treatment Pending JPS5312851A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3064776 1976-07-22
GB5357676 1976-12-22

Publications (1)

Publication Number Publication Date
JPS5312851A true JPS5312851A (en) 1978-02-04

Family

ID=26260544

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8826877A Pending JPS5312851A (en) 1976-07-22 1977-07-22 Novel phenoxyhydroxypropylamine* its preparation and its application for medical treatment

Country Status (11)

Country Link
JP (1) JPS5312851A (da)
AU (1) AU2714177A (da)
DE (1) DE2733305A1 (da)
DK (1) DK329577A (da)
ES (1) ES460866A1 (da)
FR (1) FR2359135A1 (da)
GR (1) GR61995B (da)
NL (1) NL7707949A (da)
NO (1) NO772604L (da)
PT (1) PT66781B (da)
SE (1) SE7708368L (da)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58160154U (ja) * 1983-03-01 1983-10-25 セイコーエプソン株式会社 印字装置
JP2007502259A (ja) * 2003-08-14 2007-02-08 グラクソ　グループ　リミテッド マトリックスメタロプロテイナーゼの阻害剤

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1737809B1 (en) 2004-02-27 2013-09-18 Amgen, Inc Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders
US7465804B2 (en) 2005-05-20 2008-12-16 Amgen Inc. Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders
US7582803B2 (en) 2005-09-14 2009-09-01 Amgen Inc. Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders
EP2061760A1 (en) 2006-09-07 2009-05-27 Amgen, Inc Benzo-fused compounds for use in treating metabolic disorders
CA2662305C (en) 2006-09-07 2012-04-17 Amgen Inc. Heterocyclic gpr40 modulators
ES2446419T3 (es) 2007-04-16 2014-03-07 Amgen, Inc Moduladores de GPR40 de ácidos bifenilfenoxi, tiofenil y aminofenilpropanoico sustituidos
JP5591706B2 (ja) 2007-10-10 2014-09-17 アムジエン・インコーポレーテツド 置換ビフェニルｇｐｒ４０調節因子
WO2009111056A1 (en) 2008-03-06 2009-09-11 Amgen Inc. Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders
AU2009303475B2 (en) 2008-10-15 2012-09-13 Amgen Inc. Spirocyclic GPR40 modulators
AU2024413085A1 (en) * 2023-12-28 2026-08-13 Cytosinlab Therapeutics Co., Ltd. Tdg inhibitor compound and use thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58160154U (ja) * 1983-03-01 1983-10-25 セイコーエプソン株式会社 印字装置
JP2007502259A (ja) * 2003-08-14 2007-02-08 グラクソ　グループ　リミテッド マトリックスメタロプロテイナーゼの阻害剤

Also Published As

Publication number Publication date
DE2733305A1 (de) 1978-01-26
PT66781B (fr) 1978-12-18
DK329577A (da) 1978-01-23
NL7707949A (nl) 1978-01-24
SE7708368L (sv) 1978-01-23
ES460866A1 (es) 1978-08-16
PT66781A (fr) 1977-08-01
AU2714177A (en) 1979-01-25
NO772604L (no) 1978-01-24
GR61995B (en) 1979-02-14
FR2359135A1 (fr) 1978-02-17

Similar Documents

Publication Publication Date Title
AU511855B2 (en) Skin treatment composition
JPS5581649A (en) Polymer composition for medical treatment and its preparation
JPS5233399A (en) Patient*s respirator
JPS52122632A (en) Medical composition and process for preparing same
JPS51115910A (en) Gradually releaseetype medical composition and its preparation
JPS52134026A (en) Medical composition
JPS5297921A (en) Aralkylaniline derivative* preparation thereof and medical composition containing same
JPS5334389A (en) Medical and surgical dressing
JPS549282A (en) Novel aminopiperidines*its preparation*and medical compositions
JPS5315367A (en) 22benzilpyrrolidine* preparation thereof and medicine containing same
JPS5466675A (en) Omegaamercaptopropionamido*its manufacture and medical composition
GB1518764A (en) Isobutyramides their preparation and therapeutic composititions containing them
JPS52151730A (en) Medical composition for treating and preventing relapsic thrombus
JPS52122637A (en) Composition for skin protection and treatment
JPS5441847A (en) Pseudotrisaccharides*their manufacture and their medical use
AU509040B2 (en) Dehydrooligopeptides and their medical use
JPS52102279A (en) And its preparation and medical composition containing same
JPS52133980A (en) Medical treatment using 22iminothiazolidines and thiazolines
JPS5334930A (en) Medical composition
GB2008412A (en) Dilator for application in medical field
JPS5416482A (en) Novel benzylpyrimidine*its preparation and medicine containing same
JPS5315428A (en) Medical composition
JPS5321160A (en) Novel 55thiazolealkylamine derivative* its preparation and medical composition
JPS527419A (en) Heterocolloidal deblicin containing medical composition and its preparation
AU1052676A (en) Tissue treatment